CINOXACIN - Generic Drug Details

What are the generic sources for cinoxacin and what is the scope of freedom to operate?

Cinoxacin is the generic ingredient in two branded drugs marketed by Lilly and Teva, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for CINOXACIN

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	73
Clinical Trials:	1
Patent Applications:	6,613
DailyMed Link:	CINOXACIN at DailyMed

Recent Clinical Trials for CINOXACIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Louisville	Early Phase 1
James Graham Brown Cancer Center	Early Phase 1
Julio Ramirez	Early Phase 1

See all CINOXACIN clinical trials

Medical Subject Heading (MeSH) Categories for CINOXACIN

Anti-Infective Agents

Topoisomerase II Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for CINOXACIN

J01MB	Other quinolones
J01M	QUINOLONE ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for CINOXACIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	CINOBAC	cinoxacin	CAPSULE;ORAL	018067-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Teva	CINOXACIN	cinoxacin	CAPSULE;ORAL	073006-001	Feb 28, 1992		DISCN	No	No
Teva	CINOXACIN	cinoxacin	CAPSULE;ORAL	073005-001	Feb 28, 1992		DISCN	No	No
Lilly	CINOBAC	cinoxacin	CAPSULE;ORAL	018067-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for CINOXACIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	CINOBAC	cinoxacin	CAPSULE;ORAL	018067-001	Approved Prior to Jan 1, 1982
Lilly	CINOBAC	cinoxacin	CAPSULE;ORAL	018067-002	Approved Prior to Jan 1, 1982